Here’s Why Peloton Is Much More Than a COVID Play
In fact, it’s more than a stationary bike play, too.
Mindfully Curated
In fact, it’s more than a stationary bike play, too.
Can the growth stock finally make a comeback?
Shares of Amazon and Pinterest currently trade well below their 52-week highs.
The company is pushing into live-gaming genres, and that should have investors excited.
Here’s how the biggest U.S. bank is doing.
It’s a good example of a business taking more than one step to address an opportunity.
Is the social media company’s massive drop warranted?
The results weren’t nearly as bad as last week’s sell-off made them out to be.
Want more money from Social Security? Here’s how to pull it off.
These companies could upend the industry in the years ahead.
The coffee titan is back to setting sales records.
Investors should look beyond the company’s COVID-19 vaccine.
Could this legacy automaker pivot into the next generation of transportation?
The big bank posted a rare earnings disappointment for the second quarter.
Plus your investment would be worth nearly three times its original value.
Meme stocks have had an incredible year, but there are some important lessons all investors can learn from them.
One of our top banking experts talks about where he puts his own money.
The complex deal to acquire a stake in Universal Music fell through, but should investors sell or hold?
Relax — this surprising announcement is not the end of Micron’s growth ambitions.
The FDA recently approved Ultomiris as a treatment for paroxysmal nocturnal hemoglobinuria patients who are under 18, and it should get a similar label expansion in the E.U. soon.